Format

Send to

Choose Destination
Ups J Med Sci. 2013 May;118(2):75-9. doi: 10.3109/03009734.2012.751471. Epub 2012 Dec 12.

Ruling out cardiac failure: cost-benefit analysis of a sequential testing strategy with NT-proBNP before echocardiography.

Author information

1
Department of Clinical Chemistry, Blekinge County Hospital, Karlskrona, Sweden. mjferrandis@gmail.com

Abstract

OBJECTIVES:

To estimate the possible economic benefit of a sequential testing strategy with NT-proBNP to reduce the number of echocardiographies.

METHODS:

Retrospective study in a third-party payer perspective. The costs were calculated from three Swedish counties: Blekinge, Östergötland, and Uppland. Two cut-off levels of NT-proBNP were used: 400 and 300 pg/mL. The cost-effectiveness of the testing strategy was estimated through the short-term cost avoidance and reduction in demand for echocardiographies.

RESULTS:

The estimated costs for NT-proBNP tests and echocardiographies per county were reduced by 33%-36% with the 400 pg/mL cut-off and by 28%-29% with the 300 pg/mL cut-off. This corresponded to a yearly cost reduction of approximately €2-5 million per million inhabitants in these counties.

CONCLUSION:

The use of NT-proBNP as a screening test could substantially reduce the number of echocardiographies in the diagnostic work-up of patients with suspected cardiac failure, as well as the associated costs.

PMID:
23230860
PMCID:
PMC3633333
DOI:
10.3109/03009734.2012.751471
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for PubMed Central
Loading ...
Support Center